Related Experiment Video
Updated: May 27, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
Published on: March 22, 2024
Cardiac device infections are associated with a significant mortality risk
Mihály K de Bie1, Johannes B van Rees, J Thijssen
1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Insights
Cardiac device infections (CDIs) significantly increase mortality risk in patients with implantable cardioverter-defibrillators or cardiac resynchronization therapy-defibrillators. Experiencing a CDI more than doubles the risk of death compared to those without infection.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Device Technology
Background:
- Cardiac device infections (CDIs) are a serious complication of cardiac rhythm device implantation.
- The impact of CDIs on long-term mortality risk remains unclear.
Purpose of the Study:
- To evaluate the prognostic significance of CDIs in patients receiving implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds).
Main Methods:
- A cohort of 2476 patients who received initial ICD/CRT-D implants between 2000 and 2009 were analyzed.
- Cardiac device infections and all-cause mortality were recorded during follow-up.
- Cox proportional hazards models with CDI as a time-dependent covariate assessed mortality risk.
Main Results:
- The 3-year incidence of CDI was 2.6% in the cohort.
- A first CDI occurred in 64 patients, with a 1-year mortality rate of 16.9%.
- Experiencing a CDI was associated with a 1.87-fold increased mortality risk (HR 1.87; 95% CI 1.07-3.26), rising to a 2.40-fold increased risk (HR 2.40; 95% CI 1.35-4.28) after adjusting for confounders.
Conclusions:
- CDIs pose a substantial risk of mortality in patients with ICDs/CRT-Ds.
- Patients who develop a CDI face a significantly elevated risk of death, more than doubling their mortality risk compared to uninfected patients.
Background:
Cardiac device infections (CDIs) are a serious complication associated with the implantation of cardiac rhythm devices. However, the effect of CDI on the subsequent risk of mortality is unknown.
Objective:
To assess the prognostic importance of CDI in recipients of implantable cardioverter-defibrillator and cardiac resynchronization therapy - defibrillator.
Methods:
All patients who received their initial implantable cardioverter-defibrillator/cardiac resynchronization therapy - defibrillator between January 2000 and September 2009 were included. During follow-up, the occurrence of CDI and all-cause mortality were noted. The prognostic importance of the first CDI on mortality was assessed by modeling CDI as a time-dependent covariate in the Cox proportional hazards model.
Results:
A total of 2476 patients (79% men; mean age 62 ± 13 years) were included in this analysis. During follow-up, CDI occurred in 64 (2.6%) patients. The 1-year mortality following first CDI was 16.9% (95% confidence interval 6.7%-27.1%). Experiencing the first CDI was associated with a 1.9-fold (hazard ratio 1.87; 95% confidence interval 1.07-3.26) increased risk of mortality compared to patients who did not experience CDI. After controlling for possible confounders, this increased to a 2.4-fold (hazard ratio 2.40; 95% confidence interval 1.35-4.28) increased risk of mortality.
Conclusions:
In a large cohort of patients who receive implantable cardioverter-defibrillator/cardiac resynchronization therapy - defibrillator after their initial implant, the 3-year incidence of CDI was 2.6%. The occurrence of CDI was associated with substantial 1-year mortality, and patients experiencing CDI had a more than 2-fold increased risk of mortality compared with patients who remained free from CDI.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Bacterial Signaling
Cardiomyopathy V: Interprofessional Care
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
